For how long should a patient who ingested eight Vistaril (hydroxyzine) tablets be observed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Observation Period for Vistaril (Hydroxyzine) Overdose

A patient who ingested eight Vistaril tablets should be observed for at least 6 hours from the time of ingestion, provided they remain asymptomatic or develop only mild drowsiness during this period.

Clinical Effects Timeline

Hydroxyzine is rapidly absorbed from the gastrointestinal tract, with clinical effects typically appearing within 15-30 minutes after oral administration 1. This rapid onset means that significant toxicity, if it will occur, should manifest relatively early in the observation period.

Evidence-Based Observation Duration

The 6-hour observation window is supported by high-quality emergency medicine research demonstrating that asymptomatic patients with selected acute intentional ingestions who are medically cleared after 6 hours of observation can often be identified within 2-4 hours of presentation 2. In this prospective study of 215 observed overdose patients, 100% of those deemed safe for early medical clearance at 2 or 4 hours were ultimately cleared at 6 hours with no complications (95% CI = 98.2% to 100%) 2.

Additionally, consensus guidelines for similar sedating medications recommend that asymptomatic patients without evidence of self-harm are unlikely to develop symptoms if the interval between ingestion and evaluation is greater than 6 hours 3.

Dose-Specific Considerations

The typical Vistaril capsule contains 25 mg or 50 mg of hydroxyzine 1. Eight tablets could represent:

  • 200 mg (eight 25 mg capsules)
  • 400 mg (eight 50 mg capsules)

Both doses exceed therapeutic levels and warrant observation, though hydroxyzine overdose typically manifests with CNS depression, anticholinergic effects, and tachycardia rather than life-threatening toxicity 4.

Monitoring During Observation

During the 6-hour period, assess for:

  • Level of consciousness (anything beyond mild drowsiness requires continued observation or admission)
  • Cardiac rhythm (sinus tachycardia is common; monitor for QT prolongation)
  • Anticholinergic signs (dry mouth, urinary retention, mydriasis)
  • Seizure activity (rare but documented in pediatric overdose) 4

Early Discharge Criteria

Patients can be medically cleared before 6 hours if:

  • They remain completely asymptomatic at 2-4 hours post-ingestion
  • Vital signs are stable
  • No suicidal intent exists
  • Reliable follow-up is available

However, if any symptoms develop or the patient has mild drowsiness at presentation, complete the full 6-hour observation 2.

Critical Pitfalls

  • Do not discharge during normal sleeping hours when reliable observation cannot be maintained 3
  • Suicidal intent mandates emergency department referral regardless of dose or symptoms 3
  • Co-ingestions change management entirely - this recommendation applies only to isolated hydroxyzine overdose 3

References

Research

Emergency department observation of poisoned patients: how long is necessary?

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.